Works about SPHINGOSINE-1-phosphate

Results: 846
    1
    2
    3

    DNA damage response and sphingolipid signaling in liver diseases.

    Published in:
    Surgery Today, 2016, v. 46, n. 9, p. 995, doi. 10.1007/s00595-015-1270-8
    By:
    • Nagahashi, Masayuki;
    • Matsuda, Yasunobu;
    • Moro, Kazuki;
    • Tsuchida, Junko;
    • Soma, Daiki;
    • Hirose, Yuki;
    • Kobayashi, Takashi;
    • Kosugi, Shin-ichi;
    • Takabe, Kazuaki;
    • Komatsu, Masaaki;
    • Wakai, Toshifumi
    Publication type:
    Article
    4

    Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods.

    Published in:
    Journal of Mammary Gland Biology & Neoplasia, 2016, v. 21, n. 1/2, p. 9, doi. 10.1007/s10911-016-9354-7
    By:
    • Nagahashi, Masayuki;
    • Yamada, Akimitsu;
    • Miyazaki, Hiroshi;
    • Allegood, Jeremy;
    • Tsuchida, Junko;
    • Aoyagi, Tomoyoshi;
    • Huang, Wei-Ching;
    • Terracina, Krista;
    • Adams, Barbara;
    • Rashid, Omar;
    • Milstien, Sheldon;
    • Wakai, Toshifumi;
    • Spiegel, Sarah;
    • Takabe, Kazuaki
    Publication type:
    Article
    5
    6
    7

    Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry Disease.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 5, p. 1233, doi. 10.3390/jcm11051233
    By:
    • Mauhin, Wladimir;
    • Tebani, Abdellah;
    • Amelin, Damien;
    • Abily-Donval, Lenaig;
    • Lamari, Foudil;
    • London, Jonathan;
    • Douillard, Claire;
    • Dussol, Bertrand;
    • Leguy-Seguin, Vanessa;
    • Noel, Esther;
    • Masseau, Agathe;
    • Lacombe, Didier;
    • Maillard, Hélène;
    • Bekri, Soumeya;
    • Lidove, Olivier;
    • Benveniste, Olivier
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    A Phase 1 First‐in‐Human Single‐Ascending‐Dose Trial With ESB1609, a Selective Agonist to the Sphingosine‐1‐Phosphate Receptor 5.

    Published in:
    Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 625, doi. 10.1002/cpdd.1256
    By:
    • France, Nicholas P.;
    • Rubino, Christopher;
    • Safir, M. Courtney;
    • Maurer, Mari;
    • Duong, Tram;
    • Singamsetty, Deepika;
    • Abd‐Elaziz, Khalid;
    • Chou, Thomas;
    • Sankaranarayanan, Sethu;
    • Ettema, Marieke;
    • Cosford, Rebecca;
    • Dogterom, Peter;
    • Liu, Enchi;
    • Barlow, Carrolee
    Publication type:
    Article
    14

    Population Pharmacokinetic Analysis of BMS‐986166, a Novel Selective Sphingosine‐1‐Phosphate‐1 Receptor Modulator, and Exposure‐Response Assessment of Lymphocyte Counts and Heart Rate in Healthy Participants.

    Published in:
    Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 8, doi. 10.1002/cpdd.878
    By:
    • Bihorel, Sébastien;
    • Singhal, Shalabh;
    • Shevell, Diane;
    • Sun, Huadong;
    • Xie, Jenny;
    • Basdeo, Shenita;
    • Liu, Ang;
    • Dutta, Santanu;
    • Ludwig, Elizabeth;
    • Huang, Hannah;
    • Lin, Kuan‐ju;
    • Fura, Aberra;
    • Throup, John;
    • Girgis, Ihab G.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Targeting sphingosine kinase-1 to inhibit melanoma.

    Published in:
    Pigment Cell & Melanoma Research, 2012, v. 25, n. 2, p. 259, doi. 10.1111/j.1755-148X.2012.00970.x
    By:
    • Madhunapantula, SubbaRao V.;
    • Hengst, Jeremy;
    • Gowda, Raghavendra;
    • Fox, Todd E.;
    • Yun, Jong K.;
    • Robertson, Gavin P.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50